Literature DB >> 9505826

Clinicopathological correlation of an excised choroidal neovascular membrane in pseudotumour cerebri.

A A Castellarin1, I K Sugino, M Nasir, M A Zarbin.   

Abstract

AIMS/
BACKGROUND: To correlate the histopathology of an excised choroidal neovascular membrane (CNV) with the clinical and angiographic findings in a 32-year-old woman with pseudotumour cerebri and a peripapillary CNV with subfoveal extension.
METHODS: The patient's visual acuity was assessed by individuals experienced in low vision refraction and who were not members of the surgical team. The CNV was excised via a conventional three port vitrectomy with subretinal dissection. The excised tissue was studied with light and electron microscopy. Preoperative and serial postoperative fluorescein angiograms (FAs) and fundus photographs were obtained to study the dissection bed.
RESULTS: One week after surgery, the FA showed mottled subfoveal choriocapillaris perfusion. Three weeks after surgery, this area showed retinal pigment epithelium (RPE) atrophy clinically, and the FA showed choriocapillaris non-perfusion. Six months after surgery, the area of RPE atrophy and the corresponding area of choriocapillaris non-perfusion had expanded. Histologically, the excised CNV disclosed hyperplastic RPE, fibrovascular tissue, and no choriocapillaris. Fragments of RPE basement were present along the external edge of the specimen. The patient's visual acuity did not improve significantly after surgery.
CONCLUSIONS: Choriocapillaris non-perfusion can develop even in young patients following CNV excision. In this particular case, it is believed that choriocapillaris atrophy was caused by incomplete ingrowth of RPE into the dissection bed following RPE removal with CNV excision. As far as is known, this is the first report describing the results of surgery for CNV secondary to papilloedema associated with pseudotumour cerebri.

Entities:  

Mesh:

Year:  1997        PMID: 9505826      PMCID: PMC1722067          DOI: 10.1136/bjo.81.11.994

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration.

Authors:  M A Nasir; I Sugino; M A Zarbin
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  [Bilateral juxtapapillary subretinal neovascularization in a case of pseudotumor cerebri].

Authors:  A Caballero-Presencia; E Diaz-Guia; M Martinez-Perez; J M Lopez-Lopez
Journal:  J Fr Ophtalmol       Date:  1986       Impact factor: 0.818

3.  Choriocapillaris regeneration in the rabbit. Ultrastructure of new endothelial tube formation.

Authors:  G E Korte
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-09       Impact factor: 4.799

4.  Pseudotumor cerebri.

Authors:  J L Keltner; N R Miller; J W Gittinger; R M Burde
Journal:  Surv Ophthalmol       Date:  1979 Mar-Apr       Impact factor: 6.048

5.  Pigment epithelial repair.

Authors:  W J Heriot; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

6.  Bilateral juxtapapillary subretinal neovascularization associated with pseudotumor cerebri.

Authors:  P H Morse; A S Leveille; J P Antel; J V Burch
Journal:  Am J Ophthalmol       Date:  1981-03       Impact factor: 5.258

7.  Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome.

Authors:  M A Thomas; H J Kaplan
Journal:  Am J Ophthalmol       Date:  1991-01-15       Impact factor: 5.258

8.  Macular changes resulting from papilloedema.

Authors:  A T Morris; M D Sanders
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638

9.  Subretinal neovascularization and papilledema associated with pseudotumor cerebri.

Authors:  R R Jamison
Journal:  Am J Ophthalmol       Date:  1978-01       Impact factor: 5.258

10.  Idiopathic intracranial hypertension. A prospective study of 50 patients.

Authors:  M Wall; D George
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

View more
  6 in total

1.  Combination photodynamic therapy and juxtascleral triamcinolone acetonide for the treatment of a peripapillary choroidal neovascular membrane associated with papilloedema.

Authors:  A Tewari; G K Shah; M S Dhalla; J B Shepherd
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

2.  Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors.

Authors:  Jie Gong; Ofer Sagiv; Hui Cai; Stephen H Tsang; Lucian V Del Priore
Journal:  Exp Eye Res       Date:  2008-03-28       Impact factor: 3.467

3.  Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.

Authors:  Cem Ozgonul; Omar Moinuddin; Metasebia Munie; Michael S Lee; M Tariq Bhatti; Klara Landau; Gregory P Van Stavern; Devin D Mackay; Maud Lebas; Lindsey B DeLott; Wayne T Cornblath; Cagri G Besirli
Journal:  J Neuroophthalmol       Date:  2019-12       Impact factor: 3.042

4.  Regression of Bilateral Peripapillary Choroidal Neovascularization Associated with Idiopathic Intracranial Hypertension after Systemic Acetazolamide Treatment.

Authors:  Omer Trivizki; Liang Wang; Prashanth Iyer; Yingying Shi; Philip J Rosenfeld; David Rabinovitch; Justin Townsend
Journal:  Case Rep Ophthalmol       Date:  2022-04-19

5.  A study on proliferation and behavior of retinal pigment epithelial cells on purified alginate films.

Authors:  Su Mi Jeong; Eun Young Kim; Ji Hye Hwang; Ga Young Lee; Su Jin Cho; Ji Yeon Bae; Jeong Eun Song; Kun Ho Yoon; Choun-Ki Joo; Dongwon Lee; Gilson Khang
Journal:  Int J Stem Cells       Date:  2011-11       Impact factor: 2.500

6.  Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to pseudotumor cerebri.

Authors:  Scott C Jamerson; Guruswami Arunagiri; Brian D Ellis; Monique J Leys
Journal:  Int Ophthalmol       Date:  2008-01-15       Impact factor: 2.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.